BIO

Listed Company · UPCOM

Price
12,500
Latest close
02 Apr 2026
P/E
EPS (TTM) 0
ROE (TTM) 9.7%
P/B
BVPS (Latest)
ROA (TTM) 8.8%

What Is Changing

BIO no longer looks like a business simply rebounding from a weak base. Revenue posted +3.4% YoY, while net margin reached 12.99% with an additional +2.1pp improvement versus the prior year. The next question is whether current profit momentum can hold through the next cycle.

  • Net Margin expanded consistently from 8.59% in 2023 to 12.99% in 2025.
  • Net Income reached a multi-period high at VND 9.8bn in 2025.
Metric 2025 2024 2023 2022
Revenue 75.2 72.7 70.0 56.3
Growth +3% +4% +24%
Net Income 9.8 7.9 6.0 7.9
Net Margin 12.99% 10.91% 8.59% 13.98%

Financial Statements

Profitability

Net margin reached 12.99% while Revenue posted +3.4% YoY.

Balance Sheet

Inventory stood at 9.3bn, liabilities at 9.6bn, and equity at 101.4bn.

Cash Flow

Operating cash flow was 13.6bn in 2024, while investing cash flow was 1.2bn.

Financing cash flow: -5.6bn.

Item 2025 2024 2023 2022
Net Revenue
75.2 72.7 70.0 56.3
Cost of Goods Sold
51.5 50.0 50.6 38.3
Gross Profit
23.8 22.7 19.4 18.0
Financial Expenses
0.0 0.0 0.3 0.5
Selling Expenses
0.7 0.6 0.5 0.3
General and Administrative Expenses
12.4 13.0 12.3 9.1
Operating Profit
12.9 10.6 8.1 9.9
Profit Before Tax
13.3 10.6 8.1 9.9
Net Income
9.8 7.9 6.0 7.9
Profit Attributable to Parent
9.8 7.9 6.0 7.9
Earnings per Share
1,100.00 881.00 668.00 875.00

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.